Kissei Pharmaceutical Co., Ltd.

KSPHF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$25,169$22,894$368$247
Short-Term Investments$23,485$23,039$23,706$23,139
Receivables$29,653$28,679$22,779$22,806
Inventory$24,979$26,296$22,798$18,987
Other Curr. Assets$3,694$3,643$5,465$4,397
Total Curr. Assets$106,980$104,551$100,641$99,342
Property Plant & Equip (Net)$27,069$24,861$185$198
Goodwill$242$309$0$0
Intangibles$1,652$1,683$1,507$1,569
Long-Term Investments$107,544$128,910$563$794
Tax Assets$566$0$3$4
Other NC Assets$2$610-$1,351-$1,425
Total NC Assets$137,075$156,373$907$1,140
Other Assets$4$5$0$0
Total Assets$244,059$260,929$1,665$1,956
Liabilities
Payables$4,602$4,893$4,617$4,104
Short-Term Debt$1,280$1,340$1,490$1,640
Tax Payable$1,474$2,380$3$29
Deferred Revenue$0$0$14$22
Other Curr. Liab.$9,222$9,050$8,833$12,949
Total Curr. Liab.$16,578$17,663$14,957$18,744
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$16,481$21,188$78$134
Other NC Liab.$875$940$8$10
Total NC Liab.$17,356$22,128$86$143
Other Liabilities$0$4$0$0
Cap. Leases$0$0$0$0
Total Liabilities$33,934$39,795$199$297
Equity
Pref Stock$0$0$0$0
Common Stock$24,356$24,356$24,356$24,356
Retained Earnings$131,488$127,310$125,576$118,183
AOCI$0$0$32,653$47,532
Other Equity$53,159$68,363$11,314$11,314
Total Equity$209,003$220,029$193,899$201,384
Supplemental Information
Minority Interest$1,122$1,107$7$7
Total Liab. & Tot. Equity$244,059$260,929$1,665$1,958
Net Debt-$23,889-$21,554$1,122$1,393